Publications by authors named "Kendra DeBusk"

Claim this Profile
C
Comparing patient global impression of severity and patient global impression of change to evaluate test-retest reliability of depression, non-small cell lung cancer, and asthma measures.
Sonya Eremenco, Wen-Hung Chen, Steven I Blum, Elizabeth Nicole Bush, Donald M Bushnell, Kendra DeBusk

Qual Life Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes among patients with HER2+ metastatic breast cancer with brain metastases.
Kendra DeBusk, Chiemeka Ike, Nicolas Lindegger, Naomi Schwartz, Andy Surinach

J Manag Care Spec Pharm· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and overall survival in HER2+ metastatic breast cancer at US community oncology practices.
Gregory A Vidal, Santosh Gautam, Anna Vlahiotis, Maxine D Fisher, Sonia Pulgar, Kendra DeBusk

Future Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of tucatinib for HER2-positive metastatic breast cancer after HER2-targeted therapy: a network meta-analysis.
Kendra DeBusk, Shaun Abeysinghe, Adrian Vickers, Anubhav Nangia, Judith Bell

Future Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden of central nervous system metastases in human epidermal growth factor receptor 2-positive breast cancer.
Naomi Rm Schwartz, Kendra DeBusk, Andres Forero-Torres, Joseph Feliciano, Vamshi Ruthwik Anupindi

Future Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preservation of quality of life in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial).
Volkmar Mueller, Andrew Wardley, Elisavet Paplomata, Erika Hamilton, Amelia Zelnak, Kendra DeBusk

Eur J Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-Small Cell Lung Cancer Symptom Assessment Questionnaire: Psychometric Performance and Regulatory Qualification of a Novel Patient-Reported Symptom Measure.
Donald M Bushnell, Thomas M Atkinson, Kelly P McCarrier, Astra M Liepa, Kendra P DeBusk

Curr Ther Res Clin Exp· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes in a phase II, North American study of alectinib in patients with -positive, crizotinib-resistant, non-small cell lung cancer.
Sai-Hong Ignatius Ou, Mark A Socinski, Shirish Gadgeel, Leena Gandhi, Howard West, Kendra Debusk

ESMO Open· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of the Crohn's disease patient-reported outcomes signs and symptoms (CD-PRO/SS) diary.
Peter D R Higgins, Gale Harding, Nancy K Leidy, Kendra DeBusk, Donald L Patrick

J Patient Rep Outcomes· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of the Ulcerative Colitis patient-reported outcomes signs and symptoms (UC-pro/SS) diary.
Peter D R Higgins, Gale Harding, Dennis A Revicki, Gary Globe, Donald L Patrick, Kendra DeBusk

J Patient Rep Outcomes· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE).
Eric L Simpson, Carsten Flohr, Lawrence F Eichenfield, Thomas Bieber, Howard Sofen, Kendra DeBusk

J Am Acad Dermatol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualitative Development and Content Validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument.
Kelly P McCarrier, Thomas M Atkinson, Kendra P A DeBusk, Astra M Liepa, Michael Scanlon

Clin Ther· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualitative and quantitative validation of the FACIT-fatigue scale in iron deficiency anemia.
Sarah Acaster, Rene Dickerhoof, Kendra DeBusk, Kristine Bernard, William Strauss

Health Qual Life Outcomes· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-cultural equivalence of the patient- and parent-reported quality of life in short stature youth (QoLISSY) questionnaire.
Monika Bullinger, Julia Quitmann, Neuza Silva, Anja Rohenkohl, John E Chaplin, Kendra DeBusk

Horm Res Paediatr· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parental perception of health-related quality of life in children and adolescents with short stature: literature review and introduction of the parent-reported QoLISSY instrument.
Julia Quitmann, Anja Rohenkohl, Monika Bullinger, John E Chaplin, Michael Herdman, Kendra DeBusk

Pediatr Endocrinol Rev· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the quality of life of health-referred children and adolescents with short stature: development and psychometric testing of the QoLISSY instrument.
Monika Bullinger, Julia Quitmann, Mick Power, Michael Herdman, Emmanuelle Mimoun, Kendra DeBusk

Health Qual Life Outcomes· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis